Recent breakthroughs have provided scientists with the ability to generate stem cells from adult tissues. Stem cells have already regenerated damaged heart tissue after a heart attack in clinical trials. Are these treatments safe and effective or is the hype surrounding them an example of medical "false news?" What does this mean for testing new drugs and for personalized medicine? This talk will be audio recorded. Daniel Bernstein, P, ’07, ’09, is the Alfred Woodley Salter and Mabel G. Salter Endowed Professor in Pediatrics and former chief of pediatric cardiology. His research focuses on using induced pluripotent stem cells to understand the regulation of cardiovascular function. His clinical practice is focused on heart failure and transplantation and he established Stanford’s first transplant clinic for children in 1986.